摘要
背景:亚油酸已经在急性胰腺炎的发病机理中揭示了。然而,大剂量亚油酸的不良影响的分子机制尚不清楚。目前的研究旨在探究大剂量亚油酸对Janus激酶2 (JAK2)-信号换能器激活的影响和对胰腺外分泌细胞转录3 (STAT3)途径、细胞因子产生和脂质生成的活化剂的影响 方法:MTT试验用来检测AR42J大鼠胰腺外分泌细胞的活力,乳酸脱氢酶测定用来检测细胞毒性。白细胞介素(IL)- 6和肿瘤坏死因子(TNF)-α被ELISA测定,JAK2,、p-JAK2,、STAT3、p- STAT3、和 脂肪酸合酶(FAS)的蛋白质表达用Western Blot测定。当AG490抑制JAK2和STAT3的表达被siRNA打断时大剂量亚油酸对JAK2-STAT3通路的影响也被检查。 结果:大鼠胰腺外分泌细胞AR42J细胞活力受到抑制而高剂量亚油酸增加细胞毒性。高剂量的亚油酸通过磷酸化和磷酸化STAT3的核定位激活了胰腺外分泌细胞JAK2、STAT3蛋白。此外,JAK2-STAT3 途径(IL-6, TNF-α and FAS)中下游蛋白的表达被高剂量的亚油酸上调。高剂量的亚油酸造成的IL-6 和TNF-α升高的水平被JAK2抑制剂AG490减弱。p-JAK2蛋白质上调,而p-STAT3, STAT3和FAS 蛋白质被STAT3-siRNA存在下高剂量的亚油酸下调。 结论:细胞毒性增加,高剂量的亚油酸通过大鼠胰腺外分泌细胞中细胞因子生成和脂质合成激活JAK2-STAT3 信号途径
关键词: JAK2
Current Molecular Medicine
Title:High-Dose Linoleic Acid Activated JAK2-STAT3 Signaling Pathway Involved in Cytokine Production and Lipogenesis in Pancreatic Exocrine Cells
Volume: 16 Issue: 7
Author(s): F. Zhu, Y. Guan, R. Zhang
Affiliation:
关键词: JAK2
摘要: Background: Linoleic acid has been implicated in the pathogenesis of acute pancreatitis. However, molecular mechanisms underlying adverse effects of large-dose linoleic acid remain unclear. Current study aimed to explore the impact of high-dose linoleic acid on the activation of Janus kinase 2 (JAK2)-signal transducers and activators of transcription 3 (STAT3) pathway, cytokine production, and lipogenesis in pancreatic exocrine cells.
Methods: MTT assay was used to detect the viability of AR42J rat pancreatic exocrine cells, and lactate dehydrogenase assay was utilized to detect cytotoxicity. Concentrations of interleukin (IL)-6 and tumor necrosis factor (TNF)-α were detected by ELISA, and protein expression of JAK2, p-JAK2, STAT3, p- STAT3, and fatty acid synthase (FAS) was examined by Western Blot. The impact of highdose linoleic acid on JAK2-STAT3 pathway was also examined when JAK2 was inhibited by AG490, and STAT3 expression was interrupted by siRNA.
Results: The cell viability of AR42J rat pancreatic exocrine cells was inhibited, and cytotoxicity was increased by high-dose linoleic acid. JAK2 and STAT3 proteins in pancreatic exocrine cells were activated by high-dose linoleic acid via phosphorylation and nuclear localization of phosphorylated STAT3. Moreover, the expression of downstream proteins in JAK2-STAT3 pathway (IL-6, TNF-α and FAS) was up-regulated by high-dose linoleic acid. The increased levels of IL-6 and TNF-α caused by high-dose linoleic acid were attenuated by JAK2 inhibitor AG490. p-JAK2 protein was up-regulated, whereas p-STAT3, STAT3 and FAS proteins were down-regulated by high-dose linoleic acid in the presence of STAT3-siRNA.
Conclusion: The cytotoxicity was increased and JAK2-STAT3 signaling pathway was activated by high-dose linoleic acid through cytokine production and lipogenesis in rat pancreatic exocrine cells.
Export Options
About this article
Cite this article as:
F. Zhu, Y. Guan, R. Zhang , High-Dose Linoleic Acid Activated JAK2-STAT3 Signaling Pathway Involved in Cytokine Production and Lipogenesis in Pancreatic Exocrine Cells, Current Molecular Medicine 2016; 16 (7) . https://dx.doi.org/10.2174/1566524016666160721143947
DOI https://dx.doi.org/10.2174/1566524016666160721143947 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Impacts of Non-coding RNAs and N<sup>6</sup>-Methyladenosine on Cancer: Past, Present and Future
Current Cancer Drug Targets Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Meet Our Editorial Board Member
Current Cancer Drug Targets Production of Retroviral Vectors: Review
Current Gene Therapy Designed Multiple Ligands for Cancer Therapy
Current Medicinal Chemistry Clinical Pharmacogenomics of Thiopurine S-methyltransferase
Current Clinical Pharmacology Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Antiangiogenesis in Myelodysplastic Syndrome
Current Cancer Drug Targets Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient
Current Cancer Therapy Reviews Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Inflammation & Allergy - Drug Targets (Discontinued) The Polyhedric Abl Kinases and their Pharmacologic Inhibitors
Current Enzyme Inhibition Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Randomised Trials of Graft Versus Host Disease Prophylaxis in Haemopoietic Stem Cell Transplantation
Reviews on Recent Clinical Trials Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells
Current Pharmaceutical Design Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?
Endocrine, Metabolic & Immune Disorders - Drug Targets Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets